SCHEMBL7696957

SCHEMBL7696957

Clc1ccc(Oc2cnc3cc4ccccc4cc3n2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 9/20 0.77
▸ L3MBTL1 Q9Y468 2/20 0.77
▸ CYP1A2 P05177 4/20 0.57
▸ CYP2C19 P33261 2/20 0.57
▸ CYP2C9 P11712 2/20 0.57
▸ ALDH1A1 P00352 5/20 0.56
▸ RAB9A P51151 3/20 0.54
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ NPC1 O15118 2/20 0.54
▸ HPGD P15428 2/20 0.54
▸ NPSR1 Q6W5P4 2/20 0.54
▸ ATM Q13315 1/20 0.54
▸ RXFP1 Q9HBX9 1/20 0.54
▸ LMNA P02545 3/20 0.49
▸ CYP3A4 P08684 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ TP53 P04637 1/20 0.49
▸ ALOX15 P16050 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7696379 0.84 HTT (0.77) HTTL3MBTL1CYP1A2CYP2C19CYP2C9
SCHEMBL7697707 0.84 HTT (0.56) HTTL3MBTL1CYP1A2CYP2C19CYP2C9
SCHEMBL7696910 0.77 HTT (0.62) HTTL3MBTL1CYP1A2CYP2C19CYP2C9
SCHEMBL6087572 0.77 HTT (0.61) HTTL3MBTL1CYP1A2CYP2C19CYP2C9
SCHEMBL17859587 0.77 HTT (0.66) HTTL3MBTL1CYP1A2CYP2C19CYP2C9
SCHEMBL30909351 0.77 HTT (0.61) HTTL3MBTL1CYP1A2CYP2C19CYP2C9
SCHEMBL18612170 0.77 HTT (0.66) HTTL3MBTL1CYP1A2CYP2C19CYP2C9
SCHEMBL10677656 0.77 HTT (0.61) HTTL3MBTL1CYP1A2CYP2C19CYP2C9
SCHEMBL8508099 0.77 HTT (0.66) HTTL3MBTL1CYP1A2CYP2C19CYP2C9
SCHEMBL6238201 0.77 HTT (0.61) HTTL3MBTL1CYP1A2CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 — — WO disclosed
Send feedback